Ravenquest Secures Health Canada Cultivation License at Edmonton Facility
(PresseBox) - RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the ?Company? or ?RavenQuest? - https://www.commodity-tv.net/c/search_adv/?v=298814) a federally-licensed producer of cannabis, is pleased to announce it has secured a Health Canada License to Cultivate at the Company?s flagship Edmonton facility.Company?s total production capacity to approximately 11,000 kg per year.
George Robinson, CEO of RavenQuest, stated ?this is a very exciting time and inflection point for our organization.arefully prepared and curated at our Markham facility and will be moved to Edmonton to begin production immediately? Robinson continued.
?Production will be ramped up rapidly and efficiently in order to meet supply agreements with our provincial partner, BCLDB, as well as major bulk buyer, Wayland Group? stated Robinson.
For more information, access RavenQuest?s investor presentation, fact sheet and videos here.
About RavenQuest BioMed Inc.
RavenQuest BioMed Inc. is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services & consulting and specialized research & development.
RavenQuest maintains a research partnership with McGill University focused upon cultivar (strain) recognition, plant stabilization and yield maximization of the cannabis plant.
On Behalf of the Board of Directors of
RAVENQUEST BIOMED INC.
"George Robinson"
Chief Executive Officer
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.
Cautionary Note Regarding Forward-Looking Statements
All statements in this press release, other than statements of historical fact, are "forward-looking information" with respect to the Company within the meaning of applicable securities laws, including statements with respect to anticipated production capacity.isks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achiewww.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 08.04.2019 - 01:42 Uhr
Sprache: Deutsch
News-ID 1548323
Anzahl Zeichen: 4715
contact information:
Contact person:
Town:
Vancouver, British Columbia
Phone:
Kategorie:
Internet
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 672 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Ravenquest Secures Health Canada Cultivation License at Edmonton Facility
"
steht unter der journalistisch-redaktionellen Verantwortung von
Swiss Resource Capital AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
